Adenocarcinoma of the colon presenting as bone metastases of unknown primary- A case report

Authors

  • Edwin Maduakonam Dim University of Uyo, Nigeria
  • Timothy Eyo Nottidge University of Uyo, Nigeria
  • Uchenna Miriam Eberechukwu Dim National Orthopaedic Hospital, Igbobi, Lagos, Nigeria
  • Emmanuel B Etuk
  • Joseph Chinedum Itie
  • Felix Uduma Uduma
  • Ita O Ita
  • Daniel E David

Keywords:

Osseous metastases, unknown primary, adenocarcinoma of the colon

Abstract

The liver and lung are the usual sites of distant metastasis from colorectal tumours. Bone metastasis in patients with colorectal carcinoma is considered extremely rare. It often signifies the terminal phase of colon carcinoma with a median survival of less than ten months. High index of suspicion is required, and the possibility or risk of osseous metastases arising from primary lesion in the colon should be borne in mind when assessing bony lesions that present initially as metastasis of unknown origin. We present a case of adenocarcinoma of the colon which remained undiagnosed until patient reported with a pathological fracture of the humerus and paraparesis

 

 

Author Biographies

  • Edwin Maduakonam Dim, University of Uyo, Nigeria
    Department of Orthopaedics and Traumatology
  • Timothy Eyo Nottidge, University of Uyo, Nigeria
    Department of Orthopaedics and Traumatology, Faculty of Clinical Sciences

References

Assi R, Mukherji D, Haydar A, Saroufim M, Temraz S, Shamseddine A. Metastatic colorectal cancer presenting with bone marrow metastasis: a case series and review of literature. Journal of Gastrointestinal Oncology 2015;7(2):284-297. Available at http://dx.doi.org/10.3978/j.issn.2078-6891.2015.092

Schlüter K, Gassmann P, Enns A, et al. Organ-Specific Metastatic Tumour Cell Adhesion and Extravasation of Colon Carcinoma Cells with Different Metastatic Potential. American Journal of Pathology 2006; 169:1064-73.

Katoh M, Unakami M, Hara M, et al. Bone metastasis from colorectal cancer in autopsy cases. Journal of Gastroenterology 1995;30:615-8.

Teixeira LE, Miranda RH, Ghedini DF, et al. Early complications in the orthopaedic treatment of bone metastases. Rev Bras Ortop 2009; 44:519e23.

Utzschneider S, Wicherek E, Weber P, et al. Surgical treatment of bone metastases in patients with lung cancer. Int Orthop 2011;35:731e6.

Suresh Babu MC, Sunny Garg KC, Lakshmaiah K, Babu G, Kumar RV, Loknatha D, Abraham LJ, Rajeev LK, Lokesh KN, Rudresha AH, Rao SA. Colorectal cancer presenting as bone metastasis. Journal of Cancer Research and Therapeutics 2017; 13:80-3. www.cancerjournal.net. DOI: 10.4103/0973-1482.181177.

Li AA, Cao ZY, Liu JM, Huang SH, Liu ZL. The risk factors for bone metastases in patients with colorectal cancer. Medicine 2018; 97:40(e12694). www.md-journal.com. http://dx.doi.org/10.1097/MD.0000000000012694.

Christensen TD, Jensen SG, Larsen FO, Nielsen DL. Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer. Journal of Bone Oncology 13 (2018) 97–105. https://doi.org/10.1016/j.jbo.2018.09.009.

Jimi S, Yasui T, Hotokezaka M, et al. Clinical features and prognostic factors of bone metastases from colorectal cancer. Surg Today 2013; 43:751–6.

Cassar N, Cresswell A, Moran B. Oligometastatic colorectal cancer: is single-site bony colorectal metastasis a treatable condition? Int J Colorectal Dis 2017;32:1229–31

Hung H, Chen JS, Yeh CY, et al. Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients. Int J Colorectal Dis 2017; 32:1775–8.

Dim EM, Yau CHR, Ho WYK, Lam YL. Profile of surgically treated metastatic bone tumours in a university hospital in Hong Kong. Journal of Orthopaedics, Trauma and Rehabilitation 2017; 24: 1-8. http://dx.doi.org/10.1016/j.jotr.2017.03.002

Siddique I, Stirling AJ. Focus on the surgical management of spinal cord compression. J Bone Joint Surg Br 2010:1-5.

Downloads

Additional Files

Published

2021-01-23

Issue

Vol. 5 No. 2 (2020): December 2020

Section

Journal of Biomedical and Clinical Sciences

License

JBCS Publication Ethics

JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.

Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.

Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.

This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.

Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.

Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.

In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).

Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors  without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.

CONFLICT OF INTEREST

Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.

Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.

HUMAN AND ANIMAL RIGHTS

All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.

Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.

A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.

INFORMED CONSENT

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.

DATA SHARING POLICY

JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible

Authors who do not wish to share their data must state that data will not be shared, and give the reason.

COPYRIGHT NOTICE

The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.

While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.